D
TriSalus Life Sciences, Inc. TLSI
$5.10 $0.173.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 43.00% 57.70% 49.41% -20.09% -3.37%
Total Depreciation and Amortization -2.78% 7.85% 6.87% 67.89% 59.42%
Total Amortization of Deferred Charges 213.48% -- -- -- --
Total Other Non-Cash Items -39.36% -111.57% -134.44% 514.78% -51.72%
Change in Net Operating Assets 67.41% -1,113.16% -1,878.21% -25,570.83% -219.74%
Cash from Operations 48.53% 32.32% 19.25% 10.86% -65.22%
Capital Expenditure -30.18% -59.66% 41.33% -58.81% -130.72%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- 0.00% 0.00%
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- 1,570.59% 137.50%
Cash from Investing 47.83% 37.15% 78.27% 55.17% -9.60%
Total Debt Issued -60.00% -- -- -- --
Total Debt Repaid -29.89% -52.87% 3.45% 54.69% 49.12%
Issuance of Common Stock 357.25% 288.89% 8,622.35% 10,930.43% 7,206.38%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -100.00% -81.45%
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -106.25% -108.72% -107.26% -107.31% --
Cash from Financing -43.50% -10.69% -30.56% -42.17% 186.45%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -21.05% 434.82% -232.03% -207.53% 219.57%